Rodney Hicks

As head of the Centre for Cancer Imaging, a major focus of Professor Rod Hicks’ research has been the use of positron emission tomography (PET) to provide molecular characterisation of cancer in order to improve selection and planning of cancer treatment and monitoring response to novel targeted therapeutics. In addition, he is actively involved in radionuclide therapy with a major focus on neuroendocrine tumours. He has published over 300 peer-reviewed papers and acts as Joint Editor-in-Chief of Cancer Imaging. He is also an editorial board member of the Journal of Nuclear Medicine, the European Journal of Nuclear Medicine and Molecular Imaging, the quarterly Journal of Nuclear Medicine, Current Medical Imaging Reviews and Leukaemia and Lymphoma.